Caveolin-1, referred to in the above section as exosomal CD63, was reported to be increased in plasma-derived exosomes of melanoma patients, with even higher sensitivity than CD63 as a putative melanoma biomarker (81). The gene discussed is CAV1; the disease is melanoma.